TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CLMT

Calumet, Inc.

Basic Materials · Specialty Chemicals · listed since 2006

46.70$ -5.9% vs. previous close Closing price · As of: Nov 2, 2026
🔔 Watch stock
Add to watchlist

Share this page

LinkedIn WhatsApp Email

Stock Watch

Stock Watch will tell you what changes at Calumet, Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 18.20 $ to 59.10 $ · Last price: 46.70 $ (As of: November 2, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 4.1$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 88m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 68.5%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.8

Performance

Perf. 1M ?Price performance over the last month. 0.90%
Perf. 3M ?Price performance over the last 3 months. 11.80%
Perf. 6M ?Price performance over the last 6 months. 81.80%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 65.20%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -11.6%
Perf. 1Y ?Price performance over the last 12 months. 138.91%
Perf. 3Y ?Price performance over the last 3 years. 254.55%
Perf. 5Y ?Price performance over the last 5 years. 320.99%
Perf. 10Y ?Price performance over the last 10 years. 1,216.34%
Perf. Since Inception ?Price performance since the first available trading day (01/26/2006) — with a complete history, that is since the IPO. 433.87%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 54.70$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 53.70$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 38.70$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 34.0
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 47.2%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 44.2%

Calculated from the price history · as of 11/03/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. –
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 46.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 0.7
P/B ?Price-to-book ratio: market value relative to book equity. 29.3
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 0.9
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 86.3
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 27.4

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 6.9%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. -27.8%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. -3.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -1,172.2%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -1.3%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. very low -37.9%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. -2.2
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone 0.14
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 3 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 3.60%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). –
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -1.25%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 4.95%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 109.40%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 2
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 86
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. Top 10% 95
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (57 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Specialty Chemicals

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Calumet, Inc. CLMT 4.1 – 86.3 6.9 -27.8 -1.3 138.9
Linde plc LIN 240.3 34.7 19.3 47.9 28.5 3.0 25.9
Ecolab Inc ECL 87.0 42.7 24.1 44.0 16.9 2.2 19.1
Sherwin-Williams Co SHW 85.3 34.5 19.7 48.6 14.2 2.1 -3.5
Air Products and Chemicals Inc APD 70.8 33.3 50.8 32.1 23.6 -0.5 32.8
PPG Industries Inc PPG 27.9 17.8 10.8 41.2 13.7 0.2 25.9
International Flavors & Fragrances Inc. IFF 24.2 29.9 65.0 36.6 10.1 -5.2 50.6
LyondellBasell Industries NV LYB 21.9 – 17.3 12.9 3.5 -25.2 53.2
Dupont De Nemours Inc DD 19.7 121.6 14.9 35.1 13.8 -44.7 39.4
Median of companies shown 27.9 34.5 19.7 36.6 13.8 -0.5 32.8

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 3,599 $M 2016 · Operating income: -40 $M 2016 · Net income: -329 $M 2017 · Revenue: 3,764 $M 2017 · Operating income: 158 $M 2017 · Net income: -104 $M 2018 · Revenue: 3,498 $M 2018 · Operating income: 123 $M 2018 · Net income: -55 $M 2019 · Revenue: 3,453 $M 2019 · Operating income: 76 $M 2019 · Net income: -44 $M 2020 · Revenue: 2,268 $M 2020 · Operating income: -72 $M 2020 · Net income: -149 $M 2021 · Revenue: 3,148 $M 2021 · Operating income: -86 $M 2021 · Net income: -255 $M 2022 · Revenue: 4,686 $M 2022 · Operating income: 132 $M 2022 · Net income: -170 $M 2023 · Revenue: 4,181 $M 2023 · Operating income: 267 $M 2023 · Net income: 48 $M 2024 · Revenue: 4,189 $M 2024 · Operating income: 8 $M 2024 · Net income: -222 $M 2025 · Revenue: 4,137 $M 2025 · Operating income: 54 $M 2025 · Net income: -34 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 3,599 -40 -329 -4.27 4 219 2,725
2017 3,764 158 -104 -1.34 -27 120 2,689
2018 3,498 123 -55 -0.71 75 -9 2,088
2019 3,453 76 -44 -0.56 192 10 1,858
2020 2,268 -72 -149 -1.90 63 -138 1,808
2021 3,148 -86 -255 -3.23 -44 -389 2,128
2022 4,686 132 -170 -2.14 101 -534 2,741
2023 4,181 267 48 0.60 -15 -492 2,751
2024 4,189 8 -222 -2.67 -46 -713 2,758
2025 4,137 54 -34 -0.39 109 -733 2,689

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 949.5 $M Q4 2025: Q1 · 993.9 $M Q1 2025: Q2 · 1,026.6 $M Q2 2025: Q3 · 1,078.0 $M Q3 2025: Q4 · 1,038.6 $M Q4 2026: Q1 · 1,029.7 $M Q1 2026: Q2 · 1,445.1 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.47 – 950 -2.80 -4.30 -3 -28
2025: Q1 -1.87 – 994 -12.30 -16.30 -111 -128
2025: Q2 -1.70 – 1,027 -9.40 -14.40 3 -11
2025: Q3 3.61 – 1,078 -2.00 29.10 100 92
2025: Q4 -0.43 – 1,039 9.40 -3.60 117 104
2026: Q1 -3.64 – 1,030 3.60 -30.80 -86 -99
2026: Q2 -1.09 35.90 1,445 40.80 -6.60 92 54

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 6 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Momentum & Trend

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 6
Price Target (average) 55.80$
Distance to price 19.5% The price target sits 19.5% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 0
Hold 4
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -1.65 -1.65 – -1.65 5,089 -248.8% 1
12/31/2027 3.20 3.20 – 3.20 4,943 293.9% 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly 12.0% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $150.4M
Market cap $4.13B
Free cash flow in year ten $467.5M
Terminal value as a share of market value 59.7%

For comparison: over the past five years free cash flow grew by 24.7% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

3 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -4.1%
  • More than 10% revenue growth is expected for the coming year 5.0%
  • Share count grows by less than 3% a year 3.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 0.1%
  • Gross margin at 40% or higher and without meaningful erosion 5.9%
  • Goodwill from acquisitions does not grow faster than revenue 5.2%
  • Net debt below twice EBITDA 9.8 x EBITDA
  • Operating cash flow covers the profits of the last three years 255 m
  • Return on capital at 15% or higher, or up versus two years ago 2.9%
  • Insiders hold at least 10% or are net buyers 20.3%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

3/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 1.6%
  • Exp. sales growth 3Y > 5% 9.3%
  • EBIT growth 10Y > 5% –
  • Exp. EBIT growth 3Y > 5% 9.3%
  • Net debt < 4x EBIT 43.1x
  • EBIT positive, 10Y straight 7
  • Max. EBIT decline < 50% 100.0%
  • Return on equity > 15% –
  • ROCE > 15% 2.9%
  • Expected return > 10% 10.8%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Oct 19, 2026 Lunin David EVP - CFO Other 7,954 0.00 –
Oct 19, 2026 Lunin David EVP - CFO Other 20,000 0.00 –
Sep 25, 2026 Morical Gregory J SVP, GENERAL COUNSEL Other 13,560 0.00 –
Sep 25, 2026 Morical Gregory J SVP, GENERAL COUNSEL Other 30,694 0.00 –
Sep 25, 2026 Borgmann Louis Todd CHIEF EXECUTIVE OFFICER Other 46,901 0.00 –
Sep 25, 2026 Borgmann Louis Todd CHIEF EXECUTIVE OFFICER Other 107,428 0.00 –
Sep 25, 2026 Fleming Bruce A EVP - MONTANA RENEWABLES Other 42,190 0.00 –
Sep 25, 2026 Fleming Bruce A EVP - MONTANA RENEWABLES Other 107,428 0.00 –
Sep 25, 2026 Mawer Stephen P Director Sell 24,555 0.00 –
Sep 25, 2026 Mawer Stephen P Director Other 61,387 0.00 –

View all insider transactions →

The company

About the Company

Calumet, Inc. fertigt, formuliert und vermarktet ein Sortiment spezialisierter Markenprodukte und erneuerbarer Kraftstoffe in Nordamerika und international.

Employees
1,540
Headquarters
Indianapolis, IN
Address
1060 N Capitol Ave., 46204-1044 Indianapolis, United States
Phone
317 328 5660
IPO Date
01/26/2006
ISIN
US1314281049
Stock Split
1:1 on 07/11/2024

Management

Management
Name Title Birth Year
Louis Todd Borgmann President, CEO & Director 1983
David A. Lunin Executive VP & CFO 1981
Gregory J. Morical Senior VP, General Counsel & Secretary 1969
Bruce A. Fleming Ph.D. Executive Vice President of Montana Renewables & Corporate Development 1957
Scott Obermeier President of Specialties 1973
John Robert Krutz Chief Accounting Officer 1976
John Kompa Director of Investor Relations –
Chris Hodges Alpha IR –

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/14/2026 Calumet, Inc. /DE (CLMT): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits SEC ↗
  • 09/01/2026 Calumet, Inc. /DE (CLMT): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/07/2026 Calumet, Inc. /DE (CLMT): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?